ArticleAnalytical chemistry2026
Toscana Virus Diagnosis via a Point-of-Care Tool Based on Disposable Optical Fiber Biosensors.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Toscana virus (TOSV) is an emerging Phlebovirus endemic to the Mediterranean region, with marked neurotropism, responsible for often undiagnosed cases of meningitis and meningoencephalitis. Rapid and precise identification is critical for medical treatment, but traditional approaches like Polymerase Chain Reaction (PCR) and serology have limits in terms of time, cost, and potential cross-reactivity. This proof-of-concept introduces a low-cost point-of-care test (POCT) based on surface plasmon resonance (SPR) in plastic optical fibers (POFs) combined with an antibody selective for TOSV nucleoprotein. The POF biosensors were tested with serial dilutions of TOSV viral culture in phosphate-buffered solution (PBS), obtaining a detection limit of 0.78 PFU/mL and a highly reproducible dose-response curve. Reliable selectivity was demonstrated in testing with different viruses, including the measles virus, the herpes simplex type 1 virus, and the sandfly fever Naples virus. The POCT capability to measure viral titers was validated by evaluating clinical cerebrospinal fluid samples from infected patients together with PCR. The obtained results were consistent with PCR, suggesting approximately 3 orders of magnitude higher analytical sensitivity and demonstrating its potential as a useful POCT for improving TOSV infection surveillance and clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.